EMAIL THIS PAGE TO A FRIEND

Biochemistry

Structure of human pancreatic lipase-related protein 2 with the lid in an open conformation.


PMID 18702514

Abstract

Access to the active site of pancreatic lipase (PL) is controlled by a surface loop, the lid, which normally undergoes conformational changes only upon addition of lipids or amphiphiles. Structures of PL with their lids in the open and functional conformation have required cocrystallization with amphiphiles. Here we report two crystal structures of wild-type and unglycosylated human pancreatic lipase-related protein 2 (HPLRP2) with the lid in an open conformation in the absence of amphiphiles. These structures solved independently are strikingly similar, with some residues of the lid being poorly defined in the electron-density map. The open conformation of the lid is however different from that previously observed in classical liganded PL, suggesting different kinetic properties for HPLRP2. Here we show that the HPLRP2 is directly inhibited by E600, does not present interfacial activation, and acts preferentially on substrates forming monomers or small aggregates (micelles) dispersed in solution like monoglycerides, phospholipids and galactolipids, whereas classical PL displays reverse properties and a high specificity for unsoluble substrates like triglycerides and diglycerides forming oil-in-water interfaces. These biochemical properties imply that the lid of HPLRP2 is likely to spontaneously adopt in solution the open conformation observed in the crystal structure. This open conformation generates a large cavity capable of accommodating the digalactose polar head of galactolipids, similar to that previously observed in the active site of the guinea pig PLRP2, but absent from the classical PL. Most of the structural and kinetic properties of HPLRP2 were found to be different from those of rat PLRP2, the structure of which was previously obtained with the lid in a closed conformation. Our findings illustrate the essential role of the lid in determining the substrate specificity and the mechanism of action of lipases.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

62287 Lipase A Candida antarctica, recombinant from Aspergillus oryzae, powder, beige, ~2 U/mg
L4777
Lipase acrylic resin, ≥5,000 U/g, recombinant, expressed in Aspergillus niger
62288 Lipase B Candida antarctica, recombinant from Aspergillus oryzae, powder, beige, ~9 U/mg
62301 Lipase from Aspergillus niger, powder (fine), ~200 U/g
L4277 Lipase from Aspergillus oryzae, ≥20,000 U/g
62285 Lipase from Aspergillus oryzae, lyophilized, powder, white, ~50 U/mg
75577 Lipase from Burkholderia sp., lyophilized powder, slightly beige, ~12 U/mg
02569 Lipase from Candida antarctica, lyophilized, powder, beige, ~0.3 U/mg
62302 Lipase from Candida rugosa, lyophilized, powder (fine), 15-25 U/mg
L1754 Lipase from Candida rugosa, Type VII, ≥700 unit/mg solid
62316 Lipase from Candida rugosa, powder, yellow-brown, ≥2 U/mg
L8525 Lipase from Candida rugosa, lyophilized powder, ≥40,000 units/mg protein
L3170
Lipase from Candida sp., recombinant, expressed in Aspergillus niger
L8906 Lipase from Mucor javanicus, lyophilized powder, ≥300 units/mg solid (using olive oil)
L9031 Lipase from Mucor miehei, lyophilized powder, ≥4,000 units/mg solid (using olive oil)
62298 Lipase from Mucor miehei, powder, slightly brown, ~1 U/mg
L0382 Lipase from porcine pancreas, Type VI-S, ≥20,000 units/mg protein, lyophilized powder
62309 Lipase from Pseudomonas cepacia, powder, light beige, ≥30 U/mg
28602 Lipase from Pseudomonas fluorescens, powder, slightly beige, ≥160 U/mg
L9518
Lipase from Pseudomonas sp., Type XIII, lyophilized powder, ≥15 units/mg solid
62310 Lipase from Rhizopus niveus, powder (fine), ≥1.5 U/mg
L3001 Lipase from wheat germ, Type I, lyophilized powder, 5-15 units/mg protein
62306 Lipase from wheat germ, ~0.1 U/mg
73940 Lipase immobilized from Candida antarctica, beads, slightly brown, >2 U/mg